Chronic Lymphocytic Leukemia (CLL/SLL)

Dr. Jennifer Brown, Ph.D., who played a role in advancing ibrutinib for patients with chronic lymphocytic leukemia (CLL), is the recipient of an LLS Translational Research Program grant, and has previously received a career development program grant.